Literature DB >> 6437394

A micromethod for the assay of aldose reductase, its application to pancreatic islets.

S P Dufrane, W J Malaisse, A Sener.   

Abstract

A micromethod for the assay of aldose reductase is described. The method, which is based on the fluorometric measurement of the NADP+ formed when an aldose is converted to its corresponding polyol, was applied to lens and pancreatic islet crude homogenates, as well as semipurified lens aldose reductase. The fluorometric method has proved to be reproducible, more rapid, and more sensitive than the classical spectrophotometric procedure, and should find ready application in the screening of potential aldose reductase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6437394     DOI: 10.1016/0006-2944(84)90012-7

Source DB:  PubMed          Journal:  Biochem Med        ISSN: 0006-2944


  5 in total

1.  Enzymes in pancreatic islets that use NADP(H) as a cofactor including evidence for a plasma membrane aldehyde reductase.

Authors:  M Laclau; F Lu; M J MacDonald
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

Review 2.  Nutrient metabolism in islet cells.

Authors:  A Sener; W J Malaisse
Journal:  Experientia       Date:  1984-10-15

3.  Glucose modulation of aldose reductase mRNA expression and its activity in cultured calf pulmonary artery endothelial cells.

Authors:  M Ohtaka; M Tawata; Y Hosaka; T Onaya
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

4.  Aldose reductase inhibitory activity of compounds from Zea mays L.

Authors:  Tae Hyeon Kim; Jin Kyu Kim; Young-Hee Kang; Jae-Yong Lee; Il Jun Kang; Soon Sung Lim
Journal:  Biomed Res Int       Date:  2013-03-17       Impact factor: 3.411

5.  Effects of Allium victorialis leaf extracts and its single compounds on aldose reductase, advanced glycation end products and TGF-β1 expression in mesangial cells.

Authors:  Young Sook Kim; Dong Ho Jung; Ik Soo Lee; So-Jin Choi; Song Yi Yu; Sea-Kwang Ku; Myung-Hwa Kim; Jin Sook Kim
Journal:  BMC Complement Altern Med       Date:  2013-10-03       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.